4//SEC Filing
Durata Therapeutics, Inc. 4
Accession 0001209191-14-070093
CIK 0001544116operating
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:33 PM ET
Size
13.3 KB
Accession
0001209191-14-070093
Insider Transaction Report
Form 4
Canaan VIII LP
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2014-08-26$2.08/sh+5,034$10,471→ 5,034 total(indirect: See Footnote) - Exercise/Conversion
Stock Option (right to buy)
2014-08-26−6,250→ 0 total(indirect: See Footnote)Exercise: $2.08Exp: 2022-02-27→ Common Stock (6,250 underlying) - Exercise/Conversion
Restricted Stock
2014-08-26−1,216→ 1,216 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (1,216 underlying)
Holdings
- 1,902,030
Common Stock
Footnotes (4)
- [F1]Shares held directly by Mr. Brenton Ahrens, a member and manager of Canaan LLC and a vice-president of Canaan Management, Inc. ("Canaan Management"). Mr. Ahrens, pursuant to an agreement with Canaan Management, is contractually obligated to assign any remuneration received for service as a director to Canaan Management. Each of Canaan VIII L.P ("Canaan L.P.") and its general partner, Canaan Partners VIII LLC ("Canaan LLC") and Canaan Management (collectively, the "Canaan Entities") disclaims beneficial ownership in the securities aheld by Mr. Ahrens, except to the extent, if any, of its pecuniary interest therein.
- [F2]Shares held directly by Canaan L.P. Canaan LLC, the general partner of Canaan L.P., may be deemed to share voting, investment and dispositive power with respect to shares held by Canaan L.P., but disclaims beneficial ownership of the securities held by Canaan L.P. except to the extent of any pecuniary interest therein.
- [F3]This option was granted on February 28, 2012 to Mr. Ahrens with respect to 6,250 shares of common stock, vesting in 36 substantially equal monthly installments over a three year period, the first installment of which vested on March 28, 2012.
- [F4]Shares of common stock which vest in 7 substantially equal monthly installments, the first installment of which vested on August 28, 2014. These shares have no expiration date.
Issuer
Durata Therapeutics, Inc.
CIK 0001544116
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001544116
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 5:33 PM ET
- Size
- 13.3 KB